Northeast Financial Consultants Inc's Q4 2022 13F Portfolio Changes: A Summary of Holdings Composition and Trends

Northeast Financial Consultants Inc is a registered investment advisory firm that manages a variety of portfolios, including the 13F portfolio. The 13F portfolio is designed to track changes in the holdings composition of a number of investment firms with over $100 million of assets under management. This article will summarize the changes that occurred in the Northeast Financial Consultants Inc 13F portfolio between Q3 and Q4 2022.

In Q3 2022, the 13F portfolio held shares of 39 stocks, with a total value of $783.49 million. This number decreased to 37 stocks with a total value of $754.76 million in Q4 2022, indicating a 3.68% reduction in the number of stocks held and a 3.67% decrease in total portfolio value.

Most stocks in the portfolio saw some changes in their holdings between Q3 and Q4 2022. Below are some of the notable changes seen in the portfolio:

Vanguard Index FDS (VUG): Northeast Financial Consultants Inc held 726,972 shares of VUG in Q3 2022, which decreased to 699,690 shares in Q4 2022. The value of the shares also declined from $155,536,000 to $149,110,000. This indicates a decrease of 4.1% in the number of shares held and a decrease of 4.14% in the value of holdings.

Pfizer Inc (PFE): Northeast Financial Consultants Inc increased its holdings in Pfizer in Q4, going from 1,902,072 shares in Q3 to 1,948,299 shares in Q4. The value of those shares increased from $83,235,000 to $99,830,000, which indicates a change of 19.90% in the number of shares held and an increase of 19.9% in the value of holdings.

Vanguard Specialized Funds (VIG): This is another stock that saw an increase in holdings in Q4. The number of shares held increased from 529,631 in Q3 to 593,037 in Q4, with the value of the shares increasing from $71,585,000 to $90,052,000. This indicates a change of 12.0% in the number of shares held and an increase of 25.80% in the value of holdings.

SPDR S&P 500 ETF TR (SPY): The number of shares held in Q4 decreased from 240,430 in Q3 to 183,369. The value of those shares decreased from $85,877,000 to $70,125,000, which represents a change of 23.68% in the number of shares held and a decrease in the value of holdings by 18.30%.

The changes seen in the portfolio reflect the changing market conditions and investor sentiment. Some of the notable trends in the portfolio include an increased focus on pharmaceutical stocks, a decrease in technology stocks, and an increased focus on finance and energy sectors. It is worth noting that some stocks saw significant changes in holdings, indicating that Northeast Financial Consultants Inc was taking advantage of new opportunities in the market.

In conclusion, Northeast Financial Consultants Inc's 13F portfolio experienced some changes between Q3 and Q4 2022, reflecting the changing market conditions and investor sentiment. While some stocks saw a decline in holdings, others experienced an increase in number and value of shares held. Overall, the portfolio changes indicate that Northeast Financial Consultants Inc continued to make strategic investment decisions in response to shifts in the market.